Global Sophocarpidine (CAS?519-02-8) Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Sophocarpidine (CAS?519-02-8) will have significant change from previous year. According to our (LP Information) latest study, the global Sophocarpidine (CAS?519-02-8) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sophocarpidine (CAS?519-02-8) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Sophocarpidine (CAS?519-02-8) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sophocarpidine (CAS?519-02-8) market, reaching US$ million by the year 2028. As for the Europe Sophocarpidine (CAS?519-02-8) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sophocarpidine (CAS?519-02-8) players cover Fujie Pharmaceutical, QHL Pharma, Select Botanical, and Indena, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sophocarpidine (CAS?519-02-8) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Sophocarpidine (CAS?519-02-8) will have significant change from previous year. According to our (LP Information) latest study, the global Sophocarpidine (CAS?519-02-8) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sophocarpidine (CAS?519-02-8) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Sophocarpidine (CAS?519-02-8) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sophocarpidine (CAS?519-02-8) market, reaching US$ million by the year 2028. As for the Europe Sophocarpidine (CAS?519-02-8) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sophocarpidine (CAS?519-02-8) players cover Fujie Pharmaceutical, QHL Pharma, Select Botanical, and Indena, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sophocarpidine (CAS?519-02-8) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- High Purity
- Low Purity
- Pharmaceuticals
- Pesticides
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fujie Pharmaceutical
- QHL Pharma
- Select Botanical
- Indena
- TIANSHAN Pharmaceuticals
- Selco Wirkstoffe Vertriebs GmbH
- Jiangsu Tiansheng Pharmaceutical
- Tiansheng Pharmaceutical
- Hubei Zhongliao Chemical Co., LTD
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sophocarpidine (CAS?519-02-8) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sophocarpidine (CAS?519-02-8) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sophocarpidine (CAS?519-02-8) by Country/Region, 2017, 2022 & 2028
2.2 Sophocarpidine (CAS?519-02-8) Segment by Type
2.2.1 High Purity
2.2.2 Low Purity
2.3 Sophocarpidine (CAS?519-02-8) Sales by Type
2.3.1 Global Sophocarpidine (CAS?519-02-8) Sales Market Share by Type (2017-2022)
2.3.2 Global Sophocarpidine (CAS?519-02-8) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sophocarpidine (CAS?519-02-8) Sale Price by Type (2017-2022)
2.4 Sophocarpidine (CAS?519-02-8) Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Pesticides
2.4.3 Others
2.5 Sophocarpidine (CAS?519-02-8) Sales by Application
2.5.1 Global Sophocarpidine (CAS?519-02-8) Sale Market Share by Application (2017-2022)
2.5.2 Global Sophocarpidine (CAS?519-02-8) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sophocarpidine (CAS?519-02-8) Sale Price by Application (2017-2022)
3 GLOBAL SOPHOCARPIDINE (CAS?519-02-8) BY COMPANY
3.1 Global Sophocarpidine (CAS?519-02-8) Breakdown Data by Company
3.1.1 Global Sophocarpidine (CAS?519-02-8) Annual Sales by Company (2020-2022)
3.1.2 Global Sophocarpidine (CAS?519-02-8) Sales Market Share by Company (2020-2022)
3.2 Global Sophocarpidine (CAS?519-02-8) Annual Revenue by Company (2020-2022)
3.2.1 Global Sophocarpidine (CAS?519-02-8) Revenue by Company (2020-2022)
3.2.2 Global Sophocarpidine (CAS?519-02-8) Revenue Market Share by Company (2020-2022)
3.3 Global Sophocarpidine (CAS?519-02-8) Sale Price by Company
3.4 Key Manufacturers Sophocarpidine (CAS?519-02-8) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sophocarpidine (CAS?519-02-8) Product Location Distribution
3.4.2 Players Sophocarpidine (CAS?519-02-8) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SOPHOCARPIDINE (CAS?519-02-8) BY GEOGRAPHIC REGION
4.1 World Historic Sophocarpidine (CAS?519-02-8) Market Size by Geographic Region (2017-2022)
4.1.1 Global Sophocarpidine (CAS?519-02-8) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sophocarpidine (CAS?519-02-8) Annual Revenue by Geographic Region
4.2 World Historic Sophocarpidine (CAS?519-02-8) Market Size by Country/Region (2017-2022)
4.2.1 Global Sophocarpidine (CAS?519-02-8) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sophocarpidine (CAS?519-02-8) Annual Revenue by Country/Region
4.3 Americas Sophocarpidine (CAS?519-02-8) Sales Growth
4.4 APAC Sophocarpidine (CAS?519-02-8) Sales Growth
4.5 Europe Sophocarpidine (CAS?519-02-8) Sales Growth
4.6 Middle East & Africa Sophocarpidine (CAS?519-02-8) Sales Growth
5 AMERICAS
5.1 Americas Sophocarpidine (CAS?519-02-8) Sales by Country
5.1.1 Americas Sophocarpidine (CAS?519-02-8) Sales by Country (2017-2022)
5.1.2 Americas Sophocarpidine (CAS?519-02-8) Revenue by Country (2017-2022)
5.2 Americas Sophocarpidine (CAS?519-02-8) Sales by Type
5.3 Americas Sophocarpidine (CAS?519-02-8) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sophocarpidine (CAS?519-02-8) Sales by Region
6.1.1 APAC Sophocarpidine (CAS?519-02-8) Sales by Region (2017-2022)
6.1.2 APAC Sophocarpidine (CAS?519-02-8) Revenue by Region (2017-2022)
6.2 APAC Sophocarpidine (CAS?519-02-8) Sales by Type
6.3 APAC Sophocarpidine (CAS?519-02-8) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sophocarpidine (CAS?519-02-8) by Country
7.1.1 Europe Sophocarpidine (CAS?519-02-8) Sales by Country (2017-2022)
7.1.2 Europe Sophocarpidine (CAS?519-02-8) Revenue by Country (2017-2022)
7.2 Europe Sophocarpidine (CAS?519-02-8) Sales by Type
7.3 Europe Sophocarpidine (CAS?519-02-8) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sophocarpidine (CAS?519-02-8) by Country
8.1.1 Middle East & Africa Sophocarpidine (CAS?519-02-8) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sophocarpidine (CAS?519-02-8) Revenue by Country (2017-2022)
8.2 Middle East & Africa Sophocarpidine (CAS?519-02-8) Sales by Type
8.3 Middle East & Africa Sophocarpidine (CAS?519-02-8) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sophocarpidine (CAS?519-02-8)
10.3 Manufacturing Process Analysis of Sophocarpidine (CAS?519-02-8)
10.4 Industry Chain Structure of Sophocarpidine (CAS?519-02-8)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sophocarpidine (CAS?519-02-8) Distributors
11.3 Sophocarpidine (CAS?519-02-8) Customer
12 WORLD FORECAST REVIEW FOR SOPHOCARPIDINE (CAS?519-02-8) BY GEOGRAPHIC REGION
12.1 Global Sophocarpidine (CAS?519-02-8) Market Size Forecast by Region
12.1.1 Global Sophocarpidine (CAS?519-02-8) Forecast by Region (2023-2028)
12.1.2 Global Sophocarpidine (CAS?519-02-8) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sophocarpidine (CAS?519-02-8) Forecast by Type
12.7 Global Sophocarpidine (CAS?519-02-8) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Fujie Pharmaceutical
13.1.1 Fujie Pharmaceutical Company Information
13.1.2 Fujie Pharmaceutical Sophocarpidine (CAS?519-02-8) Product Offered
13.1.3 Fujie Pharmaceutical Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Fujie Pharmaceutical Main Business Overview
13.1.5 Fujie Pharmaceutical Latest Developments
13.2 QHL Pharma
13.2.1 QHL Pharma Company Information
13.2.2 QHL Pharma Sophocarpidine (CAS?519-02-8) Product Offered
13.2.3 QHL Pharma Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 QHL Pharma Main Business Overview
13.2.5 QHL Pharma Latest Developments
13.3 Select Botanical
13.3.1 Select Botanical Company Information
13.3.2 Select Botanical Sophocarpidine (CAS?519-02-8) Product Offered
13.3.3 Select Botanical Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Select Botanical Main Business Overview
13.3.5 Select Botanical Latest Developments
13.4 Indena
13.4.1 Indena Company Information
13.4.2 Indena Sophocarpidine (CAS?519-02-8) Product Offered
13.4.3 Indena Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Indena Main Business Overview
13.4.5 Indena Latest Developments
13.5 TIANSHAN Pharmaceuticals
13.5.1 TIANSHAN Pharmaceuticals Company Information
13.5.2 TIANSHAN Pharmaceuticals Sophocarpidine (CAS?519-02-8) Product Offered
13.5.3 TIANSHAN Pharmaceuticals Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 TIANSHAN Pharmaceuticals Main Business Overview
13.5.5 TIANSHAN Pharmaceuticals Latest Developments
13.6 Selco Wirkstoffe Vertriebs GmbH
13.6.1 Selco Wirkstoffe Vertriebs GmbH Company Information
13.6.2 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS?519-02-8) Product Offered
13.6.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Selco Wirkstoffe Vertriebs GmbH Main Business Overview
13.6.5 Selco Wirkstoffe Vertriebs GmbH Latest Developments
13.7 Jiangsu Tiansheng Pharmaceutical
13.7.1 Jiangsu Tiansheng Pharmaceutical Company Information
13.7.2 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS?519-02-8) Product Offered
13.7.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Jiangsu Tiansheng Pharmaceutical Main Business Overview
13.7.5 Jiangsu Tiansheng Pharmaceutical Latest Developments
13.8 Tiansheng Pharmaceutical
13.8.1 Tiansheng Pharmaceutical Company Information
13.8.2 Tiansheng Pharmaceutical Sophocarpidine (CAS?519-02-8) Product Offered
13.8.3 Tiansheng Pharmaceutical Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Tiansheng Pharmaceutical Main Business Overview
13.8.5 Tiansheng Pharmaceutical Latest Developments
13.9 Hubei Zhongliao Chemical Co., LTD
13.9.1 Hubei Zhongliao Chemical Co., LTD Company Information
13.9.2 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS?519-02-8) Product Offered
13.9.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hubei Zhongliao Chemical Co., LTD Main Business Overview
13.9.5 Hubei Zhongliao Chemical Co., LTD Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sophocarpidine (CAS?519-02-8) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sophocarpidine (CAS?519-02-8) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sophocarpidine (CAS?519-02-8) by Country/Region, 2017, 2022 & 2028
2.2 Sophocarpidine (CAS?519-02-8) Segment by Type
2.2.1 High Purity
2.2.2 Low Purity
2.3 Sophocarpidine (CAS?519-02-8) Sales by Type
2.3.1 Global Sophocarpidine (CAS?519-02-8) Sales Market Share by Type (2017-2022)
2.3.2 Global Sophocarpidine (CAS?519-02-8) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sophocarpidine (CAS?519-02-8) Sale Price by Type (2017-2022)
2.4 Sophocarpidine (CAS?519-02-8) Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Pesticides
2.4.3 Others
2.5 Sophocarpidine (CAS?519-02-8) Sales by Application
2.5.1 Global Sophocarpidine (CAS?519-02-8) Sale Market Share by Application (2017-2022)
2.5.2 Global Sophocarpidine (CAS?519-02-8) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sophocarpidine (CAS?519-02-8) Sale Price by Application (2017-2022)
3 GLOBAL SOPHOCARPIDINE (CAS?519-02-8) BY COMPANY
3.1 Global Sophocarpidine (CAS?519-02-8) Breakdown Data by Company
3.1.1 Global Sophocarpidine (CAS?519-02-8) Annual Sales by Company (2020-2022)
3.1.2 Global Sophocarpidine (CAS?519-02-8) Sales Market Share by Company (2020-2022)
3.2 Global Sophocarpidine (CAS?519-02-8) Annual Revenue by Company (2020-2022)
3.2.1 Global Sophocarpidine (CAS?519-02-8) Revenue by Company (2020-2022)
3.2.2 Global Sophocarpidine (CAS?519-02-8) Revenue Market Share by Company (2020-2022)
3.3 Global Sophocarpidine (CAS?519-02-8) Sale Price by Company
3.4 Key Manufacturers Sophocarpidine (CAS?519-02-8) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sophocarpidine (CAS?519-02-8) Product Location Distribution
3.4.2 Players Sophocarpidine (CAS?519-02-8) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SOPHOCARPIDINE (CAS?519-02-8) BY GEOGRAPHIC REGION
4.1 World Historic Sophocarpidine (CAS?519-02-8) Market Size by Geographic Region (2017-2022)
4.1.1 Global Sophocarpidine (CAS?519-02-8) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sophocarpidine (CAS?519-02-8) Annual Revenue by Geographic Region
4.2 World Historic Sophocarpidine (CAS?519-02-8) Market Size by Country/Region (2017-2022)
4.2.1 Global Sophocarpidine (CAS?519-02-8) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sophocarpidine (CAS?519-02-8) Annual Revenue by Country/Region
4.3 Americas Sophocarpidine (CAS?519-02-8) Sales Growth
4.4 APAC Sophocarpidine (CAS?519-02-8) Sales Growth
4.5 Europe Sophocarpidine (CAS?519-02-8) Sales Growth
4.6 Middle East & Africa Sophocarpidine (CAS?519-02-8) Sales Growth
5 AMERICAS
5.1 Americas Sophocarpidine (CAS?519-02-8) Sales by Country
5.1.1 Americas Sophocarpidine (CAS?519-02-8) Sales by Country (2017-2022)
5.1.2 Americas Sophocarpidine (CAS?519-02-8) Revenue by Country (2017-2022)
5.2 Americas Sophocarpidine (CAS?519-02-8) Sales by Type
5.3 Americas Sophocarpidine (CAS?519-02-8) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sophocarpidine (CAS?519-02-8) Sales by Region
6.1.1 APAC Sophocarpidine (CAS?519-02-8) Sales by Region (2017-2022)
6.1.2 APAC Sophocarpidine (CAS?519-02-8) Revenue by Region (2017-2022)
6.2 APAC Sophocarpidine (CAS?519-02-8) Sales by Type
6.3 APAC Sophocarpidine (CAS?519-02-8) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sophocarpidine (CAS?519-02-8) by Country
7.1.1 Europe Sophocarpidine (CAS?519-02-8) Sales by Country (2017-2022)
7.1.2 Europe Sophocarpidine (CAS?519-02-8) Revenue by Country (2017-2022)
7.2 Europe Sophocarpidine (CAS?519-02-8) Sales by Type
7.3 Europe Sophocarpidine (CAS?519-02-8) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sophocarpidine (CAS?519-02-8) by Country
8.1.1 Middle East & Africa Sophocarpidine (CAS?519-02-8) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sophocarpidine (CAS?519-02-8) Revenue by Country (2017-2022)
8.2 Middle East & Africa Sophocarpidine (CAS?519-02-8) Sales by Type
8.3 Middle East & Africa Sophocarpidine (CAS?519-02-8) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sophocarpidine (CAS?519-02-8)
10.3 Manufacturing Process Analysis of Sophocarpidine (CAS?519-02-8)
10.4 Industry Chain Structure of Sophocarpidine (CAS?519-02-8)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sophocarpidine (CAS?519-02-8) Distributors
11.3 Sophocarpidine (CAS?519-02-8) Customer
12 WORLD FORECAST REVIEW FOR SOPHOCARPIDINE (CAS?519-02-8) BY GEOGRAPHIC REGION
12.1 Global Sophocarpidine (CAS?519-02-8) Market Size Forecast by Region
12.1.1 Global Sophocarpidine (CAS?519-02-8) Forecast by Region (2023-2028)
12.1.2 Global Sophocarpidine (CAS?519-02-8) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sophocarpidine (CAS?519-02-8) Forecast by Type
12.7 Global Sophocarpidine (CAS?519-02-8) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Fujie Pharmaceutical
13.1.1 Fujie Pharmaceutical Company Information
13.1.2 Fujie Pharmaceutical Sophocarpidine (CAS?519-02-8) Product Offered
13.1.3 Fujie Pharmaceutical Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Fujie Pharmaceutical Main Business Overview
13.1.5 Fujie Pharmaceutical Latest Developments
13.2 QHL Pharma
13.2.1 QHL Pharma Company Information
13.2.2 QHL Pharma Sophocarpidine (CAS?519-02-8) Product Offered
13.2.3 QHL Pharma Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 QHL Pharma Main Business Overview
13.2.5 QHL Pharma Latest Developments
13.3 Select Botanical
13.3.1 Select Botanical Company Information
13.3.2 Select Botanical Sophocarpidine (CAS?519-02-8) Product Offered
13.3.3 Select Botanical Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Select Botanical Main Business Overview
13.3.5 Select Botanical Latest Developments
13.4 Indena
13.4.1 Indena Company Information
13.4.2 Indena Sophocarpidine (CAS?519-02-8) Product Offered
13.4.3 Indena Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Indena Main Business Overview
13.4.5 Indena Latest Developments
13.5 TIANSHAN Pharmaceuticals
13.5.1 TIANSHAN Pharmaceuticals Company Information
13.5.2 TIANSHAN Pharmaceuticals Sophocarpidine (CAS?519-02-8) Product Offered
13.5.3 TIANSHAN Pharmaceuticals Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 TIANSHAN Pharmaceuticals Main Business Overview
13.5.5 TIANSHAN Pharmaceuticals Latest Developments
13.6 Selco Wirkstoffe Vertriebs GmbH
13.6.1 Selco Wirkstoffe Vertriebs GmbH Company Information
13.6.2 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS?519-02-8) Product Offered
13.6.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Selco Wirkstoffe Vertriebs GmbH Main Business Overview
13.6.5 Selco Wirkstoffe Vertriebs GmbH Latest Developments
13.7 Jiangsu Tiansheng Pharmaceutical
13.7.1 Jiangsu Tiansheng Pharmaceutical Company Information
13.7.2 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS?519-02-8) Product Offered
13.7.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Jiangsu Tiansheng Pharmaceutical Main Business Overview
13.7.5 Jiangsu Tiansheng Pharmaceutical Latest Developments
13.8 Tiansheng Pharmaceutical
13.8.1 Tiansheng Pharmaceutical Company Information
13.8.2 Tiansheng Pharmaceutical Sophocarpidine (CAS?519-02-8) Product Offered
13.8.3 Tiansheng Pharmaceutical Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Tiansheng Pharmaceutical Main Business Overview
13.8.5 Tiansheng Pharmaceutical Latest Developments
13.9 Hubei Zhongliao Chemical Co., LTD
13.9.1 Hubei Zhongliao Chemical Co., LTD Company Information
13.9.2 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS?519-02-8) Product Offered
13.9.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS?519-02-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hubei Zhongliao Chemical Co., LTD Main Business Overview
13.9.5 Hubei Zhongliao Chemical Co., LTD Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sophocarpidine (CAS:519-02-8) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sophocarpidine (CAS:519-02-8) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of High Purity
Table 4. Major Players of Low Purity
Table 5. Global Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 6. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 7. Global Sophocarpidine (CAS:519-02-8) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Type (2017-2022)
Table 9. Global Sophocarpidine (CAS:519-02-8) Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 11. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 12. Global Sophocarpidine (CAS:519-02-8) Revenue by Application (2017-2022)
Table 13. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Application (2017-2022)
Table 14. Global Sophocarpidine (CAS:519-02-8) Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Sophocarpidine (CAS:519-02-8) Sales by Company (2020-2022) & (K MT)
Table 16. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Company (2020-2022)
Table 17. Global Sophocarpidine (CAS:519-02-8) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Company (2020-2022)
Table 19. Global Sophocarpidine (CAS:519-02-8) Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Sophocarpidine (CAS:519-02-8) Producing Area Distribution and Sales Area
Table 21. Players Sophocarpidine (CAS:519-02-8) Products Offered
Table 22. Sophocarpidine (CAS:519-02-8) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sophocarpidine (CAS:519-02-8) Sales by Geographic Region (2017-2022) & (K MT)
Table 26. Global Sophocarpidine (CAS:519-02-8) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Sophocarpidine (CAS:519-02-8) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Sophocarpidine (CAS:519-02-8) Sales by Country/Region (2017-2022) & (K MT)
Table 30. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Sophocarpidine (CAS:519-02-8) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Sophocarpidine (CAS:519-02-8) Sales by Country (2017-2022) & (K MT)
Table 34. Americas Sophocarpidine (CAS:519-02-8) Sales Market Share by Country (2017-2022)
Table 35. Americas Sophocarpidine (CAS:519-02-8) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country (2017-2022)
Table 37. Americas Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 38. Americas Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 39. Americas Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 40. Americas Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 41. APAC Sophocarpidine (CAS:519-02-8) Sales by Region (2017-2022) & (K MT)
Table 42. APAC Sophocarpidine (CAS:519-02-8) Sales Market Share by Region (2017-2022)
Table 43. APAC Sophocarpidine (CAS:519-02-8) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Sophocarpidine (CAS:519-02-8) Revenue Market Share by Region (2017-2022)
Table 45. APAC Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 46. APAC Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 47. APAC Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 48. APAC Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 49. Europe Sophocarpidine (CAS:519-02-8) Sales by Country (2017-2022) & (K MT)
Table 50. Europe Sophocarpidine (CAS:519-02-8) Sales Market Share by Country (2017-2022)
Table 51. Europe Sophocarpidine (CAS:519-02-8) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country (2017-2022)
Table 53. Europe Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 54. Europe Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 55. Europe Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 56. Europe Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales by Country (2017-2022) & (K MT)
Table 58. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 62. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 64. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Sophocarpidine (CAS:519-02-8)
Table 66. Key Market Challenges & Risks of Sophocarpidine (CAS:519-02-8)
Table 67. Key Industry Trends of Sophocarpidine (CAS:519-02-8)
Table 68. Sophocarpidine (CAS:519-02-8) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Sophocarpidine (CAS:519-02-8) Distributors List
Table 71. Sophocarpidine (CAS:519-02-8) Customer List
Table 72. Global Sophocarpidine (CAS:519-02-8) Sales Forecast by Region (2023-2028) & (K MT)
Table 73. Global Sophocarpidine (CAS:519-02-8) Sales Market Forecast by Region
Table 74. Global Sophocarpidine (CAS:519-02-8) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Sophocarpidine (CAS:519-02-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 77. Americas Sophocarpidine (CAS:519-02-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Sophocarpidine (CAS:519-02-8) Sales Forecast by Region (2023-2028) & (K MT)
Table 79. APAC Sophocarpidine (CAS:519-02-8) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Sophocarpidine (CAS:519-02-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Europe Sophocarpidine (CAS:519-02-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Sophocarpidine (CAS:519-02-8) Sales Forecast by Type (2023-2028) & (K MT)
Table 85. Global Sophocarpidine (CAS:519-02-8) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Sophocarpidine (CAS:519-02-8) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Sophocarpidine (CAS:519-02-8) Sales Forecast by Application (2023-2028) & (K MT)
Table 89. Global Sophocarpidine (CAS:519-02-8) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Sophocarpidine (CAS:519-02-8) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Fujie Pharmaceutical Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 93. Fujie Pharmaceutical Sophocarpidine (CAS:519-02-8) Product Offered
Table 94. Fujie Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Fujie Pharmaceutical Main Business
Table 96. Fujie Pharmaceutical Latest Developments
Table 97. QHL Pharma Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 98. QHL Pharma Sophocarpidine (CAS:519-02-8) Product Offered
Table 99. QHL Pharma Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. QHL Pharma Main Business
Table 101. QHL Pharma Latest Developments
Table 102. Select Botanical Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 103. Select Botanical Sophocarpidine (CAS:519-02-8) Product Offered
Table 104. Select Botanical Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Select Botanical Main Business
Table 106. Select Botanical Latest Developments
Table 107. Indena Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 108. Indena Sophocarpidine (CAS:519-02-8) Product Offered
Table 109. Indena Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Indena Main Business
Table 111. Indena Latest Developments
Table 112. TIANSHAN Pharmaceuticals Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 113. TIANSHAN Pharmaceuticals Sophocarpidine (CAS:519-02-8) Product Offered
Table 114. TIANSHAN Pharmaceuticals Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. TIANSHAN Pharmaceuticals Main Business
Table 116. TIANSHAN Pharmaceuticals Latest Developments
Table 117. Selco Wirkstoffe Vertriebs GmbH Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 118. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS:519-02-8) Product Offered
Table 119. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Selco Wirkstoffe Vertriebs GmbH Main Business
Table 121. Selco Wirkstoffe Vertriebs GmbH Latest Developments
Table 122. Jiangsu Tiansheng Pharmaceutical Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 123. Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Product Offered
Table 124. Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 125. Jiangsu Tiansheng Pharmaceutical Main Business
Table 126. Jiangsu Tiansheng Pharmaceutical Latest Developments
Table 127. Tiansheng Pharmaceutical Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 128. Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Product Offered
Table 129. Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 130. Tiansheng Pharmaceutical Main Business
Table 131. Tiansheng Pharmaceutical Latest Developments
Table 132. Hubei Zhongliao Chemical Co., LTD Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 133. Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS:519-02-8) Product Offered
Table 134. Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 135. Hubei Zhongliao Chemical Co., LTD Main Business
Table 136. Hubei Zhongliao Chemical Co., LTD Latest Developments
Table 1. Sophocarpidine (CAS:519-02-8) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sophocarpidine (CAS:519-02-8) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of High Purity
Table 4. Major Players of Low Purity
Table 5. Global Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 6. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 7. Global Sophocarpidine (CAS:519-02-8) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Type (2017-2022)
Table 9. Global Sophocarpidine (CAS:519-02-8) Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 11. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 12. Global Sophocarpidine (CAS:519-02-8) Revenue by Application (2017-2022)
Table 13. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Application (2017-2022)
Table 14. Global Sophocarpidine (CAS:519-02-8) Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Sophocarpidine (CAS:519-02-8) Sales by Company (2020-2022) & (K MT)
Table 16. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Company (2020-2022)
Table 17. Global Sophocarpidine (CAS:519-02-8) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Company (2020-2022)
Table 19. Global Sophocarpidine (CAS:519-02-8) Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Sophocarpidine (CAS:519-02-8) Producing Area Distribution and Sales Area
Table 21. Players Sophocarpidine (CAS:519-02-8) Products Offered
Table 22. Sophocarpidine (CAS:519-02-8) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sophocarpidine (CAS:519-02-8) Sales by Geographic Region (2017-2022) & (K MT)
Table 26. Global Sophocarpidine (CAS:519-02-8) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Sophocarpidine (CAS:519-02-8) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Sophocarpidine (CAS:519-02-8) Sales by Country/Region (2017-2022) & (K MT)
Table 30. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Sophocarpidine (CAS:519-02-8) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Sophocarpidine (CAS:519-02-8) Sales by Country (2017-2022) & (K MT)
Table 34. Americas Sophocarpidine (CAS:519-02-8) Sales Market Share by Country (2017-2022)
Table 35. Americas Sophocarpidine (CAS:519-02-8) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country (2017-2022)
Table 37. Americas Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 38. Americas Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 39. Americas Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 40. Americas Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 41. APAC Sophocarpidine (CAS:519-02-8) Sales by Region (2017-2022) & (K MT)
Table 42. APAC Sophocarpidine (CAS:519-02-8) Sales Market Share by Region (2017-2022)
Table 43. APAC Sophocarpidine (CAS:519-02-8) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Sophocarpidine (CAS:519-02-8) Revenue Market Share by Region (2017-2022)
Table 45. APAC Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 46. APAC Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 47. APAC Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 48. APAC Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 49. Europe Sophocarpidine (CAS:519-02-8) Sales by Country (2017-2022) & (K MT)
Table 50. Europe Sophocarpidine (CAS:519-02-8) Sales Market Share by Country (2017-2022)
Table 51. Europe Sophocarpidine (CAS:519-02-8) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country (2017-2022)
Table 53. Europe Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 54. Europe Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 55. Europe Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 56. Europe Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales by Country (2017-2022) & (K MT)
Table 58. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales by Type (2017-2022) & (K MT)
Table 62. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales by Application (2017-2022) & (K MT)
Table 64. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Sophocarpidine (CAS:519-02-8)
Table 66. Key Market Challenges & Risks of Sophocarpidine (CAS:519-02-8)
Table 67. Key Industry Trends of Sophocarpidine (CAS:519-02-8)
Table 68. Sophocarpidine (CAS:519-02-8) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Sophocarpidine (CAS:519-02-8) Distributors List
Table 71. Sophocarpidine (CAS:519-02-8) Customer List
Table 72. Global Sophocarpidine (CAS:519-02-8) Sales Forecast by Region (2023-2028) & (K MT)
Table 73. Global Sophocarpidine (CAS:519-02-8) Sales Market Forecast by Region
Table 74. Global Sophocarpidine (CAS:519-02-8) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Sophocarpidine (CAS:519-02-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 77. Americas Sophocarpidine (CAS:519-02-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Sophocarpidine (CAS:519-02-8) Sales Forecast by Region (2023-2028) & (K MT)
Table 79. APAC Sophocarpidine (CAS:519-02-8) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Sophocarpidine (CAS:519-02-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Europe Sophocarpidine (CAS:519-02-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Sophocarpidine (CAS:519-02-8) Sales Forecast by Type (2023-2028) & (K MT)
Table 85. Global Sophocarpidine (CAS:519-02-8) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Sophocarpidine (CAS:519-02-8) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Sophocarpidine (CAS:519-02-8) Sales Forecast by Application (2023-2028) & (K MT)
Table 89. Global Sophocarpidine (CAS:519-02-8) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Sophocarpidine (CAS:519-02-8) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Fujie Pharmaceutical Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 93. Fujie Pharmaceutical Sophocarpidine (CAS:519-02-8) Product Offered
Table 94. Fujie Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Fujie Pharmaceutical Main Business
Table 96. Fujie Pharmaceutical Latest Developments
Table 97. QHL Pharma Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 98. QHL Pharma Sophocarpidine (CAS:519-02-8) Product Offered
Table 99. QHL Pharma Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. QHL Pharma Main Business
Table 101. QHL Pharma Latest Developments
Table 102. Select Botanical Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 103. Select Botanical Sophocarpidine (CAS:519-02-8) Product Offered
Table 104. Select Botanical Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Select Botanical Main Business
Table 106. Select Botanical Latest Developments
Table 107. Indena Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 108. Indena Sophocarpidine (CAS:519-02-8) Product Offered
Table 109. Indena Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Indena Main Business
Table 111. Indena Latest Developments
Table 112. TIANSHAN Pharmaceuticals Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 113. TIANSHAN Pharmaceuticals Sophocarpidine (CAS:519-02-8) Product Offered
Table 114. TIANSHAN Pharmaceuticals Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. TIANSHAN Pharmaceuticals Main Business
Table 116. TIANSHAN Pharmaceuticals Latest Developments
Table 117. Selco Wirkstoffe Vertriebs GmbH Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 118. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS:519-02-8) Product Offered
Table 119. Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Selco Wirkstoffe Vertriebs GmbH Main Business
Table 121. Selco Wirkstoffe Vertriebs GmbH Latest Developments
Table 122. Jiangsu Tiansheng Pharmaceutical Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 123. Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Product Offered
Table 124. Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 125. Jiangsu Tiansheng Pharmaceutical Main Business
Table 126. Jiangsu Tiansheng Pharmaceutical Latest Developments
Table 127. Tiansheng Pharmaceutical Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 128. Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Product Offered
Table 129. Tiansheng Pharmaceutical Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 130. Tiansheng Pharmaceutical Main Business
Table 131. Tiansheng Pharmaceutical Latest Developments
Table 132. Hubei Zhongliao Chemical Co., LTD Basic Information, Sophocarpidine (CAS:519-02-8) Manufacturing Base, Sales Area and Its Competitors
Table 133. Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS:519-02-8) Product Offered
Table 134. Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS:519-02-8) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 135. Hubei Zhongliao Chemical Co., LTD Main Business
Table 136. Hubei Zhongliao Chemical Co., LTD Latest Developments
LIST OF FIGURES
Figure 1. Picture of Sophocarpidine (CAS:519-02-8)
Figure 2. Sophocarpidine (CAS:519-02-8) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sophocarpidine (CAS:519-02-8) Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Sophocarpidine (CAS:519-02-8) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sophocarpidine (CAS:519-02-8) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of High Purity
Figure 10. Product Picture of Low Purity
Figure 11. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Type in 2021
Figure 12. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Type (2017-2022)
Figure 13. Sophocarpidine (CAS:519-02-8) Consumed in Pharmaceuticals
Figure 14. Global Sophocarpidine (CAS:519-02-8) Market: Pharmaceuticals (2017-2022) & (K MT)
Figure 15. Sophocarpidine (CAS:519-02-8) Consumed in Pesticides
Figure 16. Global Sophocarpidine (CAS:519-02-8) Market: Pesticides (2017-2022) & (K MT)
Figure 17. Sophocarpidine (CAS:519-02-8) Consumed in Others
Figure 18. Global Sophocarpidine (CAS:519-02-8) Market: Others (2017-2022) & (K MT)
Figure 19. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Figure 20. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Application in 2021
Figure 21. Sophocarpidine (CAS:519-02-8) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Company in 2021
Figure 23. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Geographic Region in 2021
Figure 25. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Region (2017-2022)
Figure 26. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country/Region in 2021
Figure 27. Americas Sophocarpidine (CAS:519-02-8) Sales 2017-2022 (K MT)
Figure 28. Americas Sophocarpidine (CAS:519-02-8) Revenue 2017-2022 ($ Millions)
Figure 29. APAC Sophocarpidine (CAS:519-02-8) Sales 2017-2022 (K MT)
Figure 30. APAC Sophocarpidine (CAS:519-02-8) Revenue 2017-2022 ($ Millions)
Figure 31. Europe Sophocarpidine (CAS:519-02-8) Sales 2017-2022 (K MT)
Figure 32. Europe Sophocarpidine (CAS:519-02-8) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales 2017-2022 (K MT)
Figure 34. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue 2017-2022 ($ Millions)
Figure 35. Americas Sophocarpidine (CAS:519-02-8) Sales Market Share by Country in 2021
Figure 36. Americas Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country in 2021
Figure 37. United States Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Sophocarpidine (CAS:519-02-8) Sales Market Share by Region in 2021
Figure 42. APAC Sophocarpidine (CAS:519-02-8) Revenue Market Share by Regions in 2021
Figure 43. China Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Sophocarpidine (CAS:519-02-8) Sales Market Share by Country in 2021
Figure 50. Europe Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country in 2021
Figure 51. Germany Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country in 2021
Figure 58. Egypt Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Sophocarpidine (CAS:519-02-8) in 2021
Figure 64. Manufacturing Process Analysis of Sophocarpidine (CAS:519-02-8)
Figure 65. Industry Chain Structure of Sophocarpidine (CAS:519-02-8)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Sophocarpidine (CAS:519-02-8)
Figure 2. Sophocarpidine (CAS:519-02-8) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sophocarpidine (CAS:519-02-8) Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Sophocarpidine (CAS:519-02-8) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sophocarpidine (CAS:519-02-8) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of High Purity
Figure 10. Product Picture of Low Purity
Figure 11. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Type in 2021
Figure 12. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Type (2017-2022)
Figure 13. Sophocarpidine (CAS:519-02-8) Consumed in Pharmaceuticals
Figure 14. Global Sophocarpidine (CAS:519-02-8) Market: Pharmaceuticals (2017-2022) & (K MT)
Figure 15. Sophocarpidine (CAS:519-02-8) Consumed in Pesticides
Figure 16. Global Sophocarpidine (CAS:519-02-8) Market: Pesticides (2017-2022) & (K MT)
Figure 17. Sophocarpidine (CAS:519-02-8) Consumed in Others
Figure 18. Global Sophocarpidine (CAS:519-02-8) Market: Others (2017-2022) & (K MT)
Figure 19. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Application (2017-2022)
Figure 20. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Application in 2021
Figure 21. Sophocarpidine (CAS:519-02-8) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Company in 2021
Figure 23. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Geographic Region in 2021
Figure 25. Global Sophocarpidine (CAS:519-02-8) Sales Market Share by Region (2017-2022)
Figure 26. Global Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country/Region in 2021
Figure 27. Americas Sophocarpidine (CAS:519-02-8) Sales 2017-2022 (K MT)
Figure 28. Americas Sophocarpidine (CAS:519-02-8) Revenue 2017-2022 ($ Millions)
Figure 29. APAC Sophocarpidine (CAS:519-02-8) Sales 2017-2022 (K MT)
Figure 30. APAC Sophocarpidine (CAS:519-02-8) Revenue 2017-2022 ($ Millions)
Figure 31. Europe Sophocarpidine (CAS:519-02-8) Sales 2017-2022 (K MT)
Figure 32. Europe Sophocarpidine (CAS:519-02-8) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales 2017-2022 (K MT)
Figure 34. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue 2017-2022 ($ Millions)
Figure 35. Americas Sophocarpidine (CAS:519-02-8) Sales Market Share by Country in 2021
Figure 36. Americas Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country in 2021
Figure 37. United States Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Sophocarpidine (CAS:519-02-8) Sales Market Share by Region in 2021
Figure 42. APAC Sophocarpidine (CAS:519-02-8) Revenue Market Share by Regions in 2021
Figure 43. China Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Sophocarpidine (CAS:519-02-8) Sales Market Share by Country in 2021
Figure 50. Europe Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country in 2021
Figure 51. Germany Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Sophocarpidine (CAS:519-02-8) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Sophocarpidine (CAS:519-02-8) Revenue Market Share by Country in 2021
Figure 58. Egypt Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Sophocarpidine (CAS:519-02-8) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Sophocarpidine (CAS:519-02-8) in 2021
Figure 64. Manufacturing Process Analysis of Sophocarpidine (CAS:519-02-8)
Figure 65. Industry Chain Structure of Sophocarpidine (CAS:519-02-8)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
